HK Stock MarketDetailed Quotes

01652 FUSEN PHARM

Watchlist
  • 0.910
  • 0.0000.00%
Market Closed Nov 15 16:08 CST
672.76MMarket Cap-6842P/E (TTM)

FUSEN PHARM Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
Turnover
-41.65%196.32M
15.02%565.61M
103.15%336.44M
27.51%491.76M
-22.69%165.61M
-20.78%385.66M
-13.45%214.21M
19.51%486.85M
26.00%247.5M
-11.83%407.39M
Operating income
-41.65%196.32M
15.02%565.61M
103.15%336.44M
27.51%491.76M
-22.69%165.61M
-20.78%385.66M
-13.45%214.21M
19.51%486.85M
26.00%247.5M
-11.83%407.39M
Cost of sales
42.51%-90.45M
0.24%-266.1M
-83.19%-157.32M
-52.83%-266.74M
10.53%-85.88M
20.95%-174.53M
16.30%-95.98M
-13.28%-220.79M
-27.96%-114.67M
7.52%-194.9M
Operating expenses
42.51%-90.45M
0.24%-266.1M
-83.19%-157.32M
-52.83%-266.74M
10.53%-85.88M
20.95%-174.53M
16.30%-95.98M
-13.28%-220.79M
-27.96%-114.67M
7.52%-194.9M
Gross profit
-40.89%105.87M
33.10%299.51M
124.65%179.12M
6.58%225.02M
-32.56%79.73M
-20.65%211.13M
-10.99%118.23M
25.22%266.07M
24.35%132.83M
-15.45%212.49M
Selling expenses
33.98%-52.22M
-17.54%-139.54M
-77.36%-79.09M
-30.54%-118.72M
12.41%-44.59M
15.33%-90.95M
9.76%-50.91M
4.79%-107.41M
0.83%-56.42M
-25.92%-112.81M
Administrative expenses
-1.28%-36.21M
-36.81%-74.9M
-28.14%-35.76M
16.08%-54.75M
11.50%-27.9M
17.29%-65.24M
33.98%-31.53M
-34.30%-78.87M
-84.29%-47.76M
-19.12%-58.73M
Research and development expenses
-137.47%-57.06M
-329.61%-65.2M
---24.03M
---15.18M
----
----
----
----
----
----
Impairment and provision
----
----
----
----
----
----
----
---22.64M
----
----
-Goodwill impairment
----
----
----
----
----
----
----
---22.64M
----
----
Special items of operating profit
313.44%3.08M
-98.02%146K
-2,431.58%-1.44M
362.13%7.38M
-100.52%-57K
-159.46%-2.82M
119.95%11.06M
-81.21%4.73M
-40.77%5.03M
6.57%25.19M
Operating profit
-194.17%-36.54M
-54.26%20.02M
440.55%38.8M
-16.07%43.76M
-84.68%7.18M
-15.75%52.14M
39.10%46.85M
-6.45%61.88M
3.62%33.68M
-51.39%66.15M
Financing income
-97.47%19K
-78.50%424K
-21.09%752K
-22.91%1.97M
-21.37%953K
79.01%2.56M
51.69%1.21M
-60.99%1.43M
-9.62%799K
9.47%3.66M
Financing cost
-146.41%-7.38M
47.64%-9.27M
72.50%-2.99M
-83.29%-17.7M
-53.86%-10.88M
-5.42%-9.66M
-46.37%-7.07M
13.04%-9.16M
16.87%-4.83M
32.48%-10.53M
Share of profits of associates
-24.45%-1.07M
1.05%-9.11M
72.27%-859K
32.52%-9.2M
-62.20%-3.1M
---13.64M
---1.91M
----
----
----
Share of profit from joint venture company
97.18%-361K
5.33%-11.19M
-775.85%-12.81M
-201.26%-11.82M
-112.47%-1.46M
-51.88%11.67M
-4.17%11.72M
434.77%24.25M
--12.23M
--4.54M
Special items of earning before tax
----
46.51%-20.33M
----
-97.13%-38.01M
----
---19.28M
----
----
----
----
Earning before tax
-297.96%-45.33M
4.98%-29.45M
413.09%22.9M
-230.27%-30.99M
-114.40%-7.31M
-69.66%23.79M
21.30%50.8M
22.86%78.41M
51.87%41.88M
-48.46%63.81M
Tax
229.88%8.38M
-87.03%-6.85M
-2,832.63%-6.45M
49.00%-3.66M
103.38%236K
54.39%-7.18M
17.27%-6.99M
-36.19%-15.74M
-119.86%-8.45M
47.25%-11.56M
After-tax profit from continuing operations
-324.65%-36.95M
-4.74%-36.3M
332.40%16.45M
-308.60%-34.65M
-116.15%-7.08M
-73.49%16.61M
31.05%43.81M
19.92%62.67M
40.86%33.43M
-48.72%52.26M
Earning after tax
-324.65%-36.95M
-4.74%-36.3M
332.40%16.45M
-308.60%-34.65M
-116.15%-7.08M
-73.49%16.61M
31.05%43.81M
19.92%62.67M
40.86%33.43M
-48.72%52.26M
Minority profit
11.11%-8K
63.27%-18K
77.50%-9K
-53.13%-49K
63.64%-40K
99.57%-32K
92.69%-110K
-535.15%-7.46M
-2,053.25%-1.5M
-4,451.85%-1.18M
Profit attributable to shareholders
-324.48%-36.94M
-4.83%-36.28M
333.85%16.46M
-307.90%-34.61M
-116.02%-7.04M
-76.27%16.65M
25.72%43.92M
31.25%70.13M
47.68%34.93M
-47.55%53.43M
Basic earnings per share
-350.00%-0.05
0.00%-0.05
300.00%0.02
-350.00%-0.05
-116.67%-0.01
-77.78%0.02
50.00%0.06
28.57%0.09
33.33%0.04
-53.33%0.07
Diluted earnings per share
-350.00%-0.05
0.00%-0.05
300.00%0.02
-350.00%-0.05
-116.67%-0.01
-77.78%0.02
50.00%0.06
28.57%0.09
33.33%0.04
-53.33%0.07
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
KPMG
--
KPMG
--
KPMG
--
KPMG
--
KPMG
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019
Turnover -41.65%196.32M15.02%565.61M103.15%336.44M27.51%491.76M-22.69%165.61M-20.78%385.66M-13.45%214.21M19.51%486.85M26.00%247.5M-11.83%407.39M
Operating income -41.65%196.32M15.02%565.61M103.15%336.44M27.51%491.76M-22.69%165.61M-20.78%385.66M-13.45%214.21M19.51%486.85M26.00%247.5M-11.83%407.39M
Cost of sales 42.51%-90.45M0.24%-266.1M-83.19%-157.32M-52.83%-266.74M10.53%-85.88M20.95%-174.53M16.30%-95.98M-13.28%-220.79M-27.96%-114.67M7.52%-194.9M
Operating expenses 42.51%-90.45M0.24%-266.1M-83.19%-157.32M-52.83%-266.74M10.53%-85.88M20.95%-174.53M16.30%-95.98M-13.28%-220.79M-27.96%-114.67M7.52%-194.9M
Gross profit -40.89%105.87M33.10%299.51M124.65%179.12M6.58%225.02M-32.56%79.73M-20.65%211.13M-10.99%118.23M25.22%266.07M24.35%132.83M-15.45%212.49M
Selling expenses 33.98%-52.22M-17.54%-139.54M-77.36%-79.09M-30.54%-118.72M12.41%-44.59M15.33%-90.95M9.76%-50.91M4.79%-107.41M0.83%-56.42M-25.92%-112.81M
Administrative expenses -1.28%-36.21M-36.81%-74.9M-28.14%-35.76M16.08%-54.75M11.50%-27.9M17.29%-65.24M33.98%-31.53M-34.30%-78.87M-84.29%-47.76M-19.12%-58.73M
Research and development expenses -137.47%-57.06M-329.61%-65.2M---24.03M---15.18M------------------------
Impairment and provision -------------------------------22.64M--------
-Goodwill impairment -------------------------------22.64M--------
Special items of operating profit 313.44%3.08M-98.02%146K-2,431.58%-1.44M362.13%7.38M-100.52%-57K-159.46%-2.82M119.95%11.06M-81.21%4.73M-40.77%5.03M6.57%25.19M
Operating profit -194.17%-36.54M-54.26%20.02M440.55%38.8M-16.07%43.76M-84.68%7.18M-15.75%52.14M39.10%46.85M-6.45%61.88M3.62%33.68M-51.39%66.15M
Financing income -97.47%19K-78.50%424K-21.09%752K-22.91%1.97M-21.37%953K79.01%2.56M51.69%1.21M-60.99%1.43M-9.62%799K9.47%3.66M
Financing cost -146.41%-7.38M47.64%-9.27M72.50%-2.99M-83.29%-17.7M-53.86%-10.88M-5.42%-9.66M-46.37%-7.07M13.04%-9.16M16.87%-4.83M32.48%-10.53M
Share of profits of associates -24.45%-1.07M1.05%-9.11M72.27%-859K32.52%-9.2M-62.20%-3.1M---13.64M---1.91M------------
Share of profit from joint venture company 97.18%-361K5.33%-11.19M-775.85%-12.81M-201.26%-11.82M-112.47%-1.46M-51.88%11.67M-4.17%11.72M434.77%24.25M--12.23M--4.54M
Special items of earning before tax ----46.51%-20.33M-----97.13%-38.01M-------19.28M----------------
Earning before tax -297.96%-45.33M4.98%-29.45M413.09%22.9M-230.27%-30.99M-114.40%-7.31M-69.66%23.79M21.30%50.8M22.86%78.41M51.87%41.88M-48.46%63.81M
Tax 229.88%8.38M-87.03%-6.85M-2,832.63%-6.45M49.00%-3.66M103.38%236K54.39%-7.18M17.27%-6.99M-36.19%-15.74M-119.86%-8.45M47.25%-11.56M
After-tax profit from continuing operations -324.65%-36.95M-4.74%-36.3M332.40%16.45M-308.60%-34.65M-116.15%-7.08M-73.49%16.61M31.05%43.81M19.92%62.67M40.86%33.43M-48.72%52.26M
Earning after tax -324.65%-36.95M-4.74%-36.3M332.40%16.45M-308.60%-34.65M-116.15%-7.08M-73.49%16.61M31.05%43.81M19.92%62.67M40.86%33.43M-48.72%52.26M
Minority profit 11.11%-8K63.27%-18K77.50%-9K-53.13%-49K63.64%-40K99.57%-32K92.69%-110K-535.15%-7.46M-2,053.25%-1.5M-4,451.85%-1.18M
Profit attributable to shareholders -324.48%-36.94M-4.83%-36.28M333.85%16.46M-307.90%-34.61M-116.02%-7.04M-76.27%16.65M25.72%43.92M31.25%70.13M47.68%34.93M-47.55%53.43M
Basic earnings per share -350.00%-0.050.00%-0.05300.00%0.02-350.00%-0.05-116.67%-0.01-77.78%0.0250.00%0.0628.57%0.0933.33%0.04-53.33%0.07
Diluted earnings per share -350.00%-0.050.00%-0.05300.00%0.02-350.00%-0.05-116.67%-0.01-77.78%0.0250.00%0.0628.57%0.0933.33%0.04-53.33%0.07
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --KPMG--KPMG--KPMG--KPMG--KPMG

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data